Open Access2019–2020 Drug Updates in Hematologic Malignancies
Author(s) -
Heidi D Finnes
Publication year - 2021
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2021.12.3.12
Subject(s) - medicine , adverse effect , drug , clinical trial , intensive care medicine , hematologic neoplasms , drug reaction , medline , pharmacovigilance , pharmacology , cancer , political science , law
During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed pivotal clinical trial data, and covered the adverse events of these hematologic medications.